Vinayak Doraiswamy Atri Cure, Inc. (ATRC) insider trading activity

Vinayak Doraiswamy is Chief Scientific Officer of AtriCure, Inc.. Currently has a direct ownership of 71,872 shares of ATRC, which is worth approximately $2.49 Million. The most recent transaction as insider was on Aug 05, 2025, when has been sold 2,500 shares (Common Stock) at a price of $36.58 per share, resulting in proceeds of $91,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.9K

2.28% 3M change

20.22% 12M change

Total Value Held $2.49 Million

Vinayak Doraiswamy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2025	SELL Open market or private sale	$91,450 $36.58 p/Share	2,500 Reduced 3.36%	71,872 Common Stock
Jun 30 2025	BUY Grant, award, or other acquisition	$21,240 $25.84 p/Share	822 Added 1.09%	74,372 Common Stock
May 28 2025	SELL Open market or private sale	$83,600 $33.44 p/Share	2,500 Reduced 3.29%	73,550 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$374,693 $38.74 p/Share	9,672 Reduced 11.28%	76,050 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	25,938 Added 23.23%	85,722 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$13,680 $19.35 p/Share	707 Added 1.17%	59,784 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$321,259 $36.28 p/Share	8,855 Reduced 13.04%	59,077 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	28,622 Added 29.64%	67,932 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$21,227 $38.11 p/Share	557 Added 1.4%	39,310 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$186,016 $38.81 p/Share	4,793 Reduced 11.01%	38,753 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	24,140 Added 35.66%	43,546 Common Stock
Sep 15 2022	SELL Open market or private sale	$229,168 $45.99 p/Share	4,983 Reduced 20.43%	19,406 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$12,155 $34.73 p/Share	350 Added 1.41%	24,389 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$520,116 $69.59 p/Share	7,474 Reduced 23.72%	24,039 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	14,614 Added 31.68%	31,513 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$1,418 $59.1 p/Share	24 Added 0.14%	16,899 Common Stock
Jul 12 2021	SELL Open market or private sale	$637,697 $83.12 p/Share	7,672 Reduced 31.25%	16,875 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$19,568 $45.72 p/Share	428 Added 1.71%	24,547 Common Stock

Vinayak Doraiswamy

Chief Scientific Officer

Mason, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Value

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

Operation

Value

Type

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC

Account